- A Case of Hemolysis in ABO-unmatched Liver Transplantation: Use of Washed Group O Red Blood Cells and Steroids
-
Bae SH, Jang JW, Kim MS, Oh HJ, Choi JY, Han NI, Yoon SK, Han JY, Oh EJ, Kim DG
- KMID: 772780
- Korean J Gastroenterol.
- 2005 May;45(5):369-373.
Liver transplantation is the only curative therapy for patients with end-stage liver disease. The high success rate and the increasing demand for the transplantation sometimes calls for ABO-compatible but nonidentical... -
- CITED
-
- Close
- SHARE
-
- Close
- An Experience of ABO-incompatible Kidney Transplantation Using Plasmapheresis and Anti-CD20 Monoclonal Antibody
-
Moon HW, Yun YM, Hur M, Park JH, Lee HW, Chang SH, Yun IJ
- KMID: 1781614
- Korean J Lab Med.
- 2009 Dec;29(6):585-588.
- doi: 10.3343/kjlm.2009.29.6.585
Due to an extreme shortage of cadaveric kidneys, many centers in Japan successfully performed ABO-incompatible kidney transplantations using plasmapheresis, splenectomy and immunosuppression. Recently, a protocol including anti-CD20 monoclonal antibody (rituximab)... -
- CITED
-
- Close
- SHARE
-
- Close
- The First Korean Case Report of Anti-Gerbich
-
Jeon YL, Park TS, Cho SY, Oh SH, Kim MH, Kang SY, Lee WI
- KMID: 2434488
- Ann Lab Med.
- 2012 Nov;32(6):442-444.
In this study, we report the first Korean case of an anti-Gerbich (Ge) alloantibody to a high-incidence antigen that belongs to the Ge blood group system. The alloantibody was detected... -
- CITED
-
- Close
- SHARE
-
- Close
- The Outcomes of Hypertransfusion in Major ABO Incompatible Allogeneic Stem Cell Transplantation
-
Park SH, Lee MH, Lee SH, Lee KE, Park J, Park JO, Kim K, Kim WS, Jung CW, Im YH, Kang WK, Park K, Kim SW, Lee KH, Lee JH
- KMID: 1785698
- J Korean Med Sci.
- 2004 Feb;19(1):79-82.
- doi: 10.3346/jkms.2004.19.1.79
Major ABO incompatibility may be potentially associated with immediate or delayed hemolysis and delayed onset of erythropoiesis in patients receiving allogeneic hematopoietic stem cell transplantation (HSCT). To determine if hemolysis... -
- CITED
-
- Close
- SHARE
-
- Close
